- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.80 Å
- Oligo State
- homo-tetramer
- Ligands
- 2 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Covalent)
- 4 x FMN: FLAVIN MONONUCLEOTIDE(Covalent)(Non-covalent)
FMN.2: 23 residues within 4Å:- Chain A: Y.143, Y.144, S.195, A.196, T.197, A.198, S.228, Q.252, Y.254, T.280, K.349, S.371, Q.373, G.374, R.376, D.409, G.410, G.411, R.413, L.431, G.432, R.433, L.436
19 PLIP interactions:19 interactions with chain A- Hydrophobic interactions: A:Y.143, A:Y.144, A:A.198, A:R.433, A:L.436
- Hydrogen bonds: A:S.195, A:A.196, A:A.196, A:S.228, A:K.349, A:K.349, A:S.371, A:G.410, A:G.411, A:G.432, A:R.433
- Salt bridges: A:R.413, A:R.433
- pi-Cation interactions: A:R.376
FMN.3: 24 residues within 4Å:- Chain B: Y.144, S.195, A.196, T.197, A.198, S.228, Q.252, Y.254, T.280, K.349, S.371, Q.373, G.374, R.376, D.409, G.410, G.411, R.413, L.431, G.432, R.433, P.434, L.436
- Ligands: PYR.4
19 PLIP interactions:19 interactions with chain B- Hydrophobic interactions: B:Y.144, B:R.433, B:L.436
- Hydrogen bonds: B:A.196, B:A.196, B:A.198, B:S.228, B:Q.252, B:Y.254, B:K.349, B:K.349, B:S.371, B:G.410, B:G.411, B:G.432, B:R.433
- Salt bridges: B:R.413, B:R.433
- pi-Cation interactions: B:R.376
FMN.6: 23 residues within 4Å:- Chain C: Y.143, Y.144, S.195, A.196, T.197, A.198, S.228, Q.252, Y.254, T.280, K.349, S.371, Q.373, G.374, R.376, D.409, G.410, G.411, R.413, L.431, G.432, R.433, L.436
20 PLIP interactions:20 interactions with chain C- Hydrophobic interactions: C:Y.143, C:Y.144, C:A.198, C:R.433, C:L.436
- Hydrogen bonds: C:S.195, C:A.196, C:A.196, C:S.228, C:T.280, C:K.349, C:K.349, C:S.371, C:G.410, C:G.411, C:G.432, C:R.433
- Salt bridges: C:R.413, C:R.433
- pi-Cation interactions: C:R.376
FMN.7: 24 residues within 4Å:- Chain D: Y.144, S.195, A.196, T.197, A.198, S.228, Q.252, Y.254, T.280, K.349, S.371, Q.373, G.374, R.376, D.409, G.410, G.411, R.413, L.431, G.432, R.433, P.434, L.436
- Ligands: PYR.8
19 PLIP interactions:19 interactions with chain D- Hydrophobic interactions: D:Y.144, D:R.433, D:L.436
- Hydrogen bonds: D:A.196, D:A.196, D:A.198, D:S.228, D:Q.252, D:T.280, D:K.349, D:K.349, D:S.371, D:G.410, D:G.411, D:G.432, D:R.433
- Salt bridges: D:R.413, D:R.433
- pi-Cation interactions: D:R.376
- 2 x PYR: PYRUVIC ACID(Non-covalent)
PYR.4: 7 residues within 4Å:- Chain B: Y.143, A.198, Y.254, R.289, Q.373, R.376
- Ligands: FMN.3
6 PLIP interactions:6 interactions with chain B- Hydrophobic interactions: B:A.198
- Hydrogen bonds: B:Y.143, B:Y.254, B:Q.373
- Salt bridges: B:R.289, B:R.376
PYR.8: 7 residues within 4Å:- Chain D: Y.143, A.198, Y.254, R.289, Q.373, R.376
- Ligands: FMN.7
5 PLIP interactions:5 interactions with chain D- Hydrophobic interactions: D:A.198
- Hydrogen bonds: D:Y.143, D:Q.373
- Salt bridges: D:R.289, D:R.376
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Tsai, C.L. et al., Mechanistic and structural studies of H373Q flavocytochrome b2: effects of mutating the active site base. Biochemistry (2007)
- Release Date
- 2007-09-11
- Peptides
- Cytochrome b2: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.80 Å
- Oligo State
- homo-tetramer
- Ligands
- 2 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Covalent)
- 4 x FMN: FLAVIN MONONUCLEOTIDE(Covalent)(Non-covalent)
- 2 x PYR: PYRUVIC ACID(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Tsai, C.L. et al., Mechanistic and structural studies of H373Q flavocytochrome b2: effects of mutating the active site base. Biochemistry (2007)
- Release Date
- 2007-09-11
- Peptides
- Cytochrome b2: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B